{"result":[{"lastName":"Skinner","clinicalFocus":[{"focus":"Cancer > urologic oncology"},{"focus":"Bladder Cancer"},{"focus":"Continent urinary reservoir"},{"focus":"urinary tract reconstruction"},{"focus":"testis cancer"},{"focus":"Kidney Cancer"},{"focus":"Urology"}],"appointments":[{"appointment":"Professor - Med Center Line,Urology"}],"primaryAppointment":"Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=32891&type=small&showNoImage","displayName":"Eila C. Skinner","firstName":"Eila","href":"http://med.stanford.edu/profiles/cancer/researcher/Eila_Skinner","researchInterest":"My research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer.  This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management.  I have also focused on optimizing the  use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life."},{"lastName":"Brooks","clinicalFocus":[{"focus":"Male Cancers - Prostate "},{"focus":"Prostate Cancer"},{"focus":"Nerve-sparing radical prostatectomy"},{"focus":"Prostate Cancer - Urologic Oncology"},{"focus":"Urologic Cancers"},{"focus":"Urologic Cancers - Urologic Oncology"},{"focus":"Urology"}],"appointments":[{"appointment":"Professor,Urology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Professor,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=6178&type=small&showNoImage","displayName":"James D. Brooks","firstName":"James","href":"http://med.stanford.edu/profiles/cancer/researcher/James_Brooks","researchInterest":"We use genomic approaches to identify disease biomarkers.  We are most interested in translating biomarkers into clinical practice in urological diseases with a particular focus in cancer."},{"lastName":"Gill","clinicalFocus":[{"focus":"Bladder Cancer - Urologic Oncology"},{"focus":"Bladder Cancer"},{"focus":"Kidney Cancer"},{"focus":"Penile Cancer"},{"focus":"Prostate Cancer"},{"focus":"Testicular Tumors"},{"focus":"Ureteral Cancer"},{"focus":"Urethral Cancer"},{"focus":"Urologic Cancers"},{"focus":"Urology"},{"focus":"Benign Prostatic Hyperplasia"},{"focus":"Radical nerve sparing prostatectomy"},{"focus":"robotic prostatectomy"},{"focus":"Radical cystectomy"},{"focus":"Laser prostate surgery"},{"focus":"Laparoscopic kidney surgery"},{"focus":"minimially invasive BPH surgery"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Urology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4287&type=small&showNoImage","displayName":"Harcharan Gill","firstName":"Harcharan","href":"http://med.stanford.edu/profiles/cancer/researcher/Harcharan_Gill","researchInterest":"Benign Prostatic Hyperplasia- Evaluation and development of new minimally invasive techniques\r\n\r\nEndourology: developing, designing and evaluating new instruments\r\n\r\nBladder cancer: outcomes of treatment\r\n\r\nBPH: cryotherapy and HIFU"},{"lastName":"Yemoto","clinicalFocus":[],"appointments":[{"appointment":"Biosafety, Web & Compliance Specialist,Dean's Office - Finance & Administration, Health & Safety"},{"appointment":"Health & Safety Specialist,Dean's Office - Finance & Administration, Health & Safety"}],"primaryAppointment":"Biosafety, Web & Compliance Specialist,Dean's Office - Finance & Administration, Health & Safety","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=26030&type=small&showNoImage","displayName":"Cheryl Yemoto","firstName":"Cheryl","href":"http://cancer.stanford.edu/profiles/Cheryl_Yemoto","researchInterest":""},{"lastName":"Srinivas","clinicalFocus":[{"focus":"Bladder Cancer"},{"focus":"Bladder Cancer - Medical Oncology"},{"focus":"Germ Cell Tumors"},{"focus":"Germ Cell Tumors - Medical Oncology"},{"focus":"Germ Cell Tumors - Urologic Oncology"},{"focus":"Kidney Cancer"},{"focus":"Kidney Cancer - Medical Oncology"},{"focus":"Male Cancers - Penile"},{"focus":"Male Cancers - Prostate "},{"focus":"Male Cancers - Testicular "},{"focus":"Oncology (Cancer)"},{"focus":"Penile Cancer"},{"focus":"Prostate Cancer"},{"focus":"Prostate Cancer - Medical Oncology"},{"focus":"Testicular Tumors"},{"focus":"Testicular Tumors - Medical Oncology"},{"focus":"Ureteral Cancer"},{"focus":"Ureteral Cancer - Medical Oncology"},{"focus":"Urethral Cancer"},{"focus":"Urethral Cancer - Medical Oncology"},{"focus":"Urologic Cancers"},{"focus":"Urologic Cancers - Medical Oncology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4350&type=small&showNoImage","displayName":"Sandy Srinivas","firstName":"Sandhya","href":"http://med.stanford.edu/profiles/cancer/researcher/Sandhya_Srinivas","researchInterest":"Clinical interests: general oncology, genito-urinary malignancy Research interests: conducting clinical trials in advanced prostate cancer, bladder cancer and renal cell carcinoma"},{"lastName":"Desai","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor (Research),Medicine - General Medical Disciplines"},{"appointment":"Associate Professor (Research) (By courtesy),Health Research & Policy"}],"primaryAppointment":"Associate Professor (Research),Medicine - General Medical Disciplines","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=13492&type=small&showNoImage","displayName":"Manisha Desai","firstName":"Manisha","href":"http://med.stanford.edu/profiles/cancer/researcher/Manisha_Desai","researchInterest":"Dr. Desai is the Director of the Quantitative Sciences Unit.  She is interested in the application of biostatistical methods to all areas of medicine including oncology, nephrology, and endocrinology.  She works on methods for the analysis of epidemiologic studies, clinical trials, and studies with missing observations."},{"lastName":"Chung","clinicalFocus":[{"focus":"Prostate Cancer - Robotic Radical Prostatectomy"},{"focus":"Kidney Cancer - Urologic Oncology"},{"focus":"Prostate Cancer"},{"focus":"Single Port Laparoscopy"},{"focus":"Robotics"},{"focus":"Adrenal Cancer"},{"focus":"Urologic Cancers - Urologic Oncology"},{"focus":"Urology"},{"focus":"Nerve Sparing Radical Prostatectomy"},{"focus":"Laparoscopic Surgical Procedures"},{"focus":"Laparoscopic Partial Nephrectomy"},{"focus":"Robotic Partial Nephrectomy"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Urology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"MS, Dean's Office"}],"primaryAppointment":"Assistant Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7864&type=small&showNoImage","displayName":"Benjamin I. Chung","firstName":"Benjamin","href":"http://med.stanford.edu/profiles/cancer/researcher/Benjamin_Chung","researchInterest":"Renal cell carcinoma and prostate cancer outcomes research and epidemiology."},{"lastName":"Peehl","clinicalFocus":[],"appointments":[{"appointment":"Professor (Research),Urology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor (Research),Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4633&type=small&showNoImage","displayName":"Donna Peehl, PhD","firstName":"Donna","href":"http://med.stanford.edu/profiles/cancer/researcher/Donna_Peehl","researchInterest":"My research focuses on the molecular and cellular biology of the human prostate. Developing realistic experimental models is a major goal, and primary cultures of prostatic epithelial and stromal cells are my main model system. Our discoveries are relevant to prevention, detection, diagnosis and treatment of benign and malignant prostatic diseases."},{"lastName":"Leppert","clinicalFocus":[],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Urology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=10322&type=small&showNoImage","displayName":"John Leppert","firstName":"John","href":"http://med.stanford.edu/profiles/cancer/researcher/John_Leppert","researchInterest":"Our research aims to improve the global quality of care for patients with Urologic cancer with a particular focus on kidney cancer. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are investigating nanofluidic proteomic assays to diagnose kidney cancer and signatures of response to therapy. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions."},{"lastName":"Higgins","clinicalFocus":[{"focus":"Pathology and Laboratory Medicine"},{"focus":"Anatomic/Clinical Pathology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4038&type=small&showNoImage","displayName":"John Higgins","firstName":"John","href":"http://med.stanford.edu/profiles/cancer/researcher/John_Higgins","researchInterest":"I work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology."},{"lastName":"Tibshirani","clinicalFocus":[],"appointments":[{"appointment":"Professor,Health Research & Policy - Biostatistics"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Natural Sciences Cluster - Statistics"}],"primaryAppointment":"Professor,Health Research & Policy - Biostatistics","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4688&type=small&showNoImage","displayName":"Robert Tibshirani","firstName":"Robert","href":"http://med.stanford.edu/profiles/cancer/researcher/Robert_Tibshirani","researchInterest":"My research is in applied statistics and biostatistics. I specialize in \u000bcomputer-intensive methods for regression and classification, bootstrap, cross-validation\u000band statistical inference, and signal and image analysis for medical diagnosis."},{"lastName":"van de Rijn","clinicalFocus":[{"focus":"Anatomic Pathology"},{"focus":"Sarcoma"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Child Health Research Institute"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4008&type=small&showNoImage","displayName":"Matt van de Rijn","firstName":"Matt","href":"http://med.stanford.edu/profiles/cancer/researcher/Matt_van de Rijn","researchInterest":"Our research focuses on gene microarray analysis of human soft tissue tumors (sarcomas). In addition we work with tissue microarrays to characterize large numbers of novel antisera raised against peptides derived from genes found to be of interest during gene array analysis."},{"lastName":"Lavelle","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor - Med Center Line,Urology"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Associate Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=10415&type=small&showNoImage","displayName":"John Lavelle","firstName":"John","href":"http://med.stanford.edu/profiles/cancer/researcher/John_Lavelle","researchInterest":"My research interests are clinically  1) voiding dysfunction (BPH, incontinence, urinary retention, & neurogenic bladder). 2) Outcomes research and am currently developing a project to review the management of neurogenic bladder within the VA. \r\nPrior research in this field is in BPH. \r\n\r\nMy Basic science interests are in epithelial physiology particularly that of the urothelium lining the bladder. Specifically permeability properties and neuro-epithelial interactions relating to sensation"},{"lastName":"Goodman","clinicalFocus":[],"appointments":[{"appointment":"Professor,Medicine - General Medical Disciplines"},{"appointment":"Professor,Health Research & Policy - Epidemiology"}],"primaryAppointment":"Professor,Medicine - General Medical Disciplines","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=23410&type=small&showNoImage","displayName":"Steven Goodman","firstName":"Steven","href":"http://med.stanford.edu/profiles/cancer/researcher/Steven_Goodman","researchInterest":"I am interested in issues relating to the representation and measurement of evidence in medical research, and determinants of the truth of medical findings, using a Bayesian framework. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research. Finally, I have an ongoing project related to landmark clinical trials that have had great impact."},{"lastName":"Oakley-Girvan","clinicalFocus":[],"appointments":[{"appointment":"Consulting Assistant Professor,Health Research & Policy"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Consulting Assistant Professor,Health Research & Policy","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=7432&type=small&showNoImage","displayName":"Ingrid Oakley-Girvan","firstName":"Ingrid","href":"http://med.stanford.edu/profiles/cancer/researcher/Ingrid_Oakley-Girvan","researchInterest":"Evaluating factors associated with racial disparities in prostate and breast cancer diagnosis, progression and survival.\r\nEvaluating genetic factors and gene/environment interactions involved in prostate and breast cancer incidence, progression and survival.\r\nAssessing quality of life and survivorship issues two or more years after diagnosis.\r\nProviding information and community-based solutions to improve public health."},{"lastName":"Wren","clinicalFocus":[{"focus":"Surgical Oncology"},{"focus":"Colorectal Surgery"},{"focus":"General Surgery"},{"focus":"Surgical Procedures, Minimally Invasive"},{"focus":"Robotics"}],"appointments":[{"appointment":"Professor - Med Center Line,Surgery - General Surgery"}],"primaryAppointment":"Professor - Med Center Line,Surgery - General Surgery","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4440&type=small&showNoImage","displayName":"Sherry M. Wren","firstName":"Sherry","href":"http://med.stanford.edu/profiles/cancer/researcher/Sherry_Wren","researchInterest":"Our research interests are primarily in surgical oncology, especially gastrointestinal cancers. We are also developing new research studies in surgical outcomes."},{"lastName":"Rouse","clinicalFocus":[],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4491&type=small&showNoImage","displayName":"Robert V Rouse","firstName":"Robert","href":"http://med.stanford.edu/profiles/cancer/researcher/Robert_Rouse","researchInterest":"My recent research efforts are currently focused in the field of applications of immunohistology to the diagnosis of human neoplasms. This work is predominantly aimed at characterizing markers for the identification of non-lymphoid neoplasms and at establishing criteria for their evaluation in diagnostic situations."},{"lastName":"Sahoo","clinicalFocus":[],"appointments":[{"appointment":"Instructor,Pathology - Stem Cell Institute"}],"primaryAppointment":"Instructor,Pathology - Stem Cell Institute","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=10888&type=small&showNoImage","displayName":"Debashis Sahoo","firstName":"Debashis","href":"http://med.stanford.edu/profiles/cancer/researcher/Debashis_Sahoo","researchInterest":""},{"lastName":"Giaccia","clinicalFocus":[],"appointments":[{"appointment":"Professor,Radiation Oncology - Radiation and Cancer Biology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor (By courtesy),Obstetrics & Gynecology"},{"appointment":"Professor (By courtesy),Surgery"}],"primaryAppointment":"Professor,Radiation Oncology - Radiation and Cancer Biology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4141&type=small&showNoImage","displayName":"Amato J. Giaccia","firstName":"Amato","href":"http://med.stanford.edu/profiles/cancer/researcher/Amato_Giaccia","researchInterest":"During the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically."},{"lastName":"Comiter","clinicalFocus":[{"focus":"Urology"},{"focus":"female urology"},{"focus":"pelvic prolapse"},{"focus":"Benign Prostatic Hyperplasia"},{"focus":"Urinary Incontinence"},{"focus":"post-prostatectomy incontinence"},{"focus":"neuromodulation"}],"appointments":[{"appointment":"Professor - Med Center Line,Urology"},{"appointment":"Professor - Med Center Line (By courtesy),Obstetrics & Gynecology"}],"primaryAppointment":"Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8413&type=small&showNoImage","displayName":"Craig V. Comiter","firstName":"Craig","href":"http://med.stanford.edu/profiles/cancer/researcher/Craig_Comiter","researchInterest":"Using various animal models of bladder outlet obstruction as a representation of human prostatic disease, I am investigating how intervening with pharmacotherapy, neuromodulation, and other novel therapies may help to reverse the adverse changes in the bladder due to the obstruction.\r\n\r\nI also am investigating new, minimally invasive treatments for post-prostatectomy urinary incontinence.\r\n\r\nI am also investigating the role of neruomodulation in the treatment of chronic pelvic pain and IC."},{"lastName":"Sun","clinicalFocus":[],"appointments":[{"appointment":"Associate Professor,Urology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Associate Professor,Genetics"}],"primaryAppointment":"Associate Professor,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=4402&type=small&showNoImage","displayName":"Zijie Sun","firstName":"Zijie","href":"http://med.stanford.edu/profiles/cancer/researcher/Zijie_Sun","researchInterest":"My lab focuses on understanding the molecular mechanism of transcription factors that govern the transformation of normal mammalian cells to a neoplastic state. We are especially interested in the action of the nuclear hormone receptors and the interactions between the receptors and other signaling pathways in related human disorders."},{"lastName":"Eisenberg","clinicalFocus":[{"focus":"Urology"},{"focus":"Infertility, Male"},{"focus":"Erectile Dysfunction"},{"focus":"Men's Health"},{"focus":"Hypogonadism"},{"focus":"Peyronie's Disease"},{"focus":"Sexual Dysfunction, Physiological"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Urology"},{"appointment":"Member,Bio-X"},{"appointment":"Assistant Professor - Med Center Line (By courtesy),Obstetrics & Gynecology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Urology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=24292&type=small&showNoImage","displayName":"Michael Eisenberg","firstName":"Michael","href":"http://med.stanford.edu/profiles/cancer/researcher/Michael_Eisenberg","researchInterest":""},{"lastName":"Balise","clinicalFocus":[],"appointments":[{"appointment":"Sr Research Engineer,Health Research & Policy - Epidemiology"}],"primaryAppointment":"Sr Research Engineer,Health Research & Policy - Epidemiology","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=25948&type=small&showNoImage","displayName":"Raymond Balise","firstName":"Raymond","href":"http://cancer.stanford.edu/profiles/Raymond_Balise","researchInterest":""},{"lastName":"Arand","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Pediatrics"}],"primaryAppointment":"Postdoctoral Research fellow, Pediatrics","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=38372&type=small&showNoImage","displayName":"Julia Arand","firstName":"Julia","href":"http://med.stanford.edu/profiles/postdocs/researcher/Julia_Arand","researchInterest":""},{"lastName":"Sunwoo","clinicalFocus":[{"focus":"Thyroid Neoplasms"},{"focus":"Melanoma"},{"focus":"Parathyroid Neoplasms"},{"focus":"Tongue Neoplasms"},{"focus":"Otolaryngology - Head & Neck Surgery (Ear, Nose and Throat)"},{"focus":"Otolaryngology"},{"focus":"Thyroid Nodule"},{"focus":"Parotid Neoplasms"},{"focus":"Tonsillar Neoplasms"},{"focus":"Pharynx Neoplasms"},{"focus":"Cancer of the Pharynx"},{"focus":"Cancer of the Larynx"},{"focus":"Cancer Stem Cells"},{"focus":"Cancer of Mouth"},{"focus":"Cancer of Neck"},{"focus":"Cancer of the Nasopharynx"},{"focus":"Cancer of Oropharnyx"},{"focus":"Cancer of the Parotid"},{"focus":"Cancer of the Salivary Gland"}],"appointments":[{"appointment":"Assistant Professor,Otolaryngology (Head and Neck Surgery)"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor,Otolaryngology (Head and Neck Surgery)","imageUrl":"http://cancer.stanford.edu/profiles/viewImage?facultyId=8588&type=small&showNoImage","displayName":"John B. Sunwoo","firstName":"John","href":"http://med.stanford.edu/profiles/cancer/researcher/John_Sunwoo","researchInterest":"My laboratory is focused on two primary areas of research: (1) the immune response to head and neck cancer and to a tumorigenic population of cells within these malignancies called cancer stem cells; (2) the developmental programs of a special lymphocyte population involved in innate immunity called natural killer (NK) cells."}]}